Aiea Mansour

As a Biotechnologist with a Master of Science in Biotechnology from McGill University, I have a passion for cellular, molecular, and developmental biology, and a keen interest in oncology and immunology. I have developed a versatile skill set crossing various research techniques, such as assay development and validation, molecular biology, and bioinformatics, and I have demonstrated the ability to navigate diverse projects and collaborate effectively within multidisciplinary teams.

Most recently, I was a Research Associate at Providence Therapeutics, where I led the development and validation of critical assays for evaluating mRNA therapeutics and their lipid nanoparticle delivery systems. I also played a key role in mRNA and pDNA production, ensuring high-quality construct generation. Previously, I contributed to vaccine testing and development initiatives at Nexelis and biomarker selection and assay validation efforts at Forbius, delivering accurate and reliable results that supported the advancement of therapeutic development.

I also have experience in research, laboratory management, and project coordination, and I have authored multiple scientific publications and presentations. I am organized, efficient, and a quick learner, and I bring a blend of science and communication skills to my work.

HEOR Analyst – BroadstreetHEOR, Vancouver, BC

Apr 2024 – ongoing

• Support Systemic Literature Reviews (SLR) by screening 5,000+ abstracts, full text reviews , scanning clinical trials, and study mapping clinical trials to included publications.

Research Associate – Providence Therapeutics Holdings Inc, Calgary AB

Oct 2022 - Feb 2024

• Managed projects and timelines effectively, presented research findings to stakeholders, contributing to scientific knowledge dissemination in vaccine development.
• Synthesized extensive research findings into structured recommendations. Conducted thorough literature reviews and systemic analyses to inform decision-making processes. Produced comprehensive comparative analyses for strategic insights.
• Utilized software like R studio, FlowJo and PRISM for comprehensive biostatistical data analysis and reporting, generating graphs, tables, and figures.
• Created decision driving presentations, posters, and reports and successfully delivered findings to Research team and Providence key shareholders. 
• Developed and validated essential assays for evaluating in vivo samples and supporting mRNA therapeutic selection.
• Troubleshooted various assays and mRNA constructs, demonstrating problem solving skills and critical thinking skills.

Associate Scientist – Nexelis Inc., Laval, QC

Jan 2022 - Sep 2022

• Conducted neutralization assays on over 10,000 clinical trial samples for SARS-CoV-2 variants with over 80% success rate, contributing to vaccine testing and development.
• Led a team of 10 Associate Scientists, ensuring high standards in laboratory equipment maintenance, pseudoviral inventory management, and cross-functional team collaboration.
• Demonstrated exceptional ability in adhering to GCLP standards, ensuring meticulous documentation and maintaining compliance with regulatory requirements. 
• Managed multiple projects simultaneously within a dynamic environment, working on up to 3 projects in a single day, effectively prioritizing tasks, and meeting deadlines to ensure seamless project execution.

Translational Research Assistant – HyperMabs/FORBIUS, Montreal, QC

Jun 2021 - Dec 2021

• Supported indication selection by conducting a bioinformatic study using R studio focused on building gene-disease associations, offering valuable insights into potential therapeutic targets.
• Conducted comprehensive market analysis research to identify unmet medical needs and emerging trends in the healthcare industry, to indication selection. 
• Provided a detailed overview of ongoing clinical trials, including patient demographics, treatment regimens, and outcomes, to support proof of concept study design.
• Conducted assay design and assay validation to assess biomarker and therapeutic target levels, contributing directly to antibody drug design and development initiatives.

Undergraduate Researcher – University of Calgary, Calgary, AB

Aug 2019 - May 2020

• Investigated KAP1 protein's role in mammary gland differentiation and breast cancer metastasis using various laboratory techniques. 
• Technical report writing and scientific communication and presentation. 

President of the Biology Students Association – University of Calgary, Calgary, AB

Aug 2018 - May 2020

• Led a team of 20 executives and 600 students at the university to provide various academic and non-academic resources.

McGill University, Montreal, QC- MScA in Biotechnology

Sep 2020 - Dec 2021

Graduated with a 3.92 GPA. Relevant coursework: Structural Bioinformatics, Therapeutic Antibody Design, Bioinformatics, Biotechnology Ethics and Society, Biotechnology Management.

University of Calgary, Calgary, AB- Honors BSc in Cellular, Molecular & Microbial Biology

Sep 2017 - Jun 2020

First Class Honors with a 3.73 GPA. Dean's Honors List for 2018, 2019, 2020. Continuing Undergraduate Achievement Award 2018-2019 and 2019-2020. Transfer Award 2017-2018